Mary Richardson

Mary Richardson is currently Executive Vice President and Chief Scientific Officer at iuvo Bioscience, a Rochester –based R+D contract research organization. She also leads the Lumino Advisors Consulting team at iuvo BioScience and serves as a consultant for both pharmaceutical and medical device programs which involves all aspects of serving as a preclinical representative including creating and executing testing programs, issue management and preparation and defense of regulatory submissions.

She is an experienced board-certified Toxicologist (Diplomate of American Board of Toxicology; DABT) with broad-based technical skills in preclinical drug development. Mary earned her Ph.D. in Toxicology from the University of Rochester. Prior to her current role, she has held executive leadership positions at Procter and Gamble and Bausch and Lomb.

Her technical leadership in Preclinical drug development of small molecules, peptides, and medical devices has resulted in Regulatory approval and success of numerous drugs and medical devices. She has been an invited speaker at several scientific meetings and is an author on numerous publications.